Aurora Cannabis (ACB) vs Talphera (TLPH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Talphera (TLPH) has outperformed Aurora Cannabis (ACB) over the past year, losing 18.2% versus a loss of 27.4%. Over five years, ACB leads with a -93.7% price change compared with -94.7% for TLPH. Aurora Cannabis is the larger company by market cap ($280.5 million vs $56.1 million), about 5.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ACB | TLPH |
|---|---|---|
| Share price | $4.43 | $1.08 |
| Market cap | $280.46M | $56.06M |
| 1-day change | -0.67% | +2.86% |
| YTD return | +4.98% | -5.26% |
| 1-year return | -27.38% | -18.18% |
| 5-year return | -93.70% | -94.71% |
| EPS (TTM) | $-0.61 | $-0.26 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.67 | $1.57 |
| 52-week low | $2.56 | $0.69 |
| Distance from 52-week high | -33.53% | -31.21% |
| Analyst consensus | buy | none |
| Avg. price target upside | — | +189.81% |
| Average volume | 1.36M | 238.38K |
| Shares outstanding | 63.31M | 51.91M |
| Employees | 1,028 | 12 |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Aurora Cannabis is about 5.0 times larger than Talphera by market value ($280.46M vs $56.06M).
About Aurora Cannabis
ACB stock →Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products.
Healthcare · Drug Manufacturers - Specialty & Generic · 1,028 employees
About Talphera
TLPH stock →Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. The company's lead product candidate, Niyad, is a lyophilized formulation of nafamostat that acts as a regional anticoagulant for infusion into the extracorporeal circuit.
Healthcare · Drug Manufacturers - Specialty & Generic · 12 employees
ACB vs TLPH FAQ
Which is bigger, Aurora Cannabis or Talphera?
Aurora Cannabis (ACB) is larger, with a market capitalization of $280.46M compared with $56.06M for Talphera (TLPH).
Which stock has performed better over the past year, ACB or TLPH?
TLPH returned -18.18% over the past 12 months, compared with -27.38% for ACB (price return, excluding dividends). Past performance does not predict future results.
Are Aurora Cannabis and Talphera in the same industry?
Yes. Both are classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.